| | Business Summary | | Spectranetics
Corporation
develops,
manufactures,
markets
and
distributes
a
proprietary
excimer
laser
system
for
the
treatment
of
certain
coronary
and
vascular
conditions.
Its
excimer
laser
system
includes
the
CVX-300
laser
unit
and
various
fiber-optic
delivery
devices,
including
disposable
catheters
and
sheaths.
The
Company's
excimer
laser
system
is
deployed
in
the
United
States
and
Europe
for
use
in
multiple,
minimally
invasive
cardiovascular
applications,
and
is
used
in
angioplasty
to
open
clogged
or
obstructed
arteries.
It
is
also
used
to
remove
lead
wires
from
patients
with
implanted
pacemakers
or
implantable
cardioverter
defibrillators,
which
are
electronic
devices
that
regulate
the
heartbeat.
The
Company
markets
its
products
in
Europe
to
treat
artery
blockages
in
the
upper
and
lower
leg
and
to
treat
clogged
stents. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Spectranetics
Corp.
designs,
manufactures,
services
and
distributes
an
excimer
laser
unit
and
fiber
optic
delivery
system
for
the
treatment
of
certain
coronary
and
vascular
conditions.
For
the
six
months
ended
6/30/01,
revenues
fell
less
than
1%
to
$13.4
million.
Net
loss
fell
80%
to
$374
thousand.
Revenues
reflect
a
decrease
in
equipment
revenue.
Lower
loss
reflects
improved
manufacturing
efficiencies
and
higher
disposable
products
pricing. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Emile Geisenheimer, 53
Chairman | -- | Joseph Largey, 54
Pres,
CEO | $283K | Paul Samek, 48
CFO,
VP-Fin. | 170K | Lawrence Martel, Jr., 50
VP
of Operations | 124K | Bruce Ross, 52
VP
of Worldwide Sales, Marketing and Services | 293K | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/s/spnc.gif)